El Mehdi Belouad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
El Mehdi Belouad has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Adil Maleb
Mohammed I University
2 shared publications Ahlam Mbarki
2 shared publications- Bahia Rached
Laboratory of Chemistry-Physics and Biotechnology of Biomolecules and Materials, Faculty of Science and Technology, Mohammedia, Hassan II University
2 shared publications - Elmostafa Benaissa
Department of Clinical Bacteriology, Mohammed V Military Teaching Hospital, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco
2 shared publications Elmostafa El Fahime
2 shared publicationsFatna Bssaibis
Department of Clinical Bacteriology, Mohammed V Military Teaching Hospital, Rabat, Morocco
2 shared publications
Latest Publications
- Open Access
- 27 July 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (2)
Functional food development from agro-industrial fruit and vegetable by-products: Fiber-degrading capacities of indigenous lactic acid bacteria
- 27 July 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (2)
Open AccessFunctional food development from agro-industrial fruit and vegetable by-products: Fiber-degrading capacities of indigenous lactic acid bacteria
- Open Access
- 30 June 2026
- Published by Scienceline Publication in World's Veterinary Journal
- Vol. 16 (2) , 436
Molecular Investigation and Risk Assessment of Neonatal Calf Diarrhea in Morocco: Emphasis on Rotavirus and Coronavirus Infections
Neonatal calf diarrhea represents a major health and economic burden in Moroccan cattle farming and remains a leading cause of calf mortality. It is commonly associated with infectious agents such as rotavirus, bovine coronavirus, Escherichia coli, and Cryptosporidium parvum, and is often aggravated by dehydration and electrolyte imbalances. The present study aimed to update the epidemiological profile of viral pathogens involved in neonatal calf diarrhea in Morocco, with particular emphasis on rotavirus group A (RVA) and bovine coronavirus (BCoV). A total of 889 newborn calves from 20 farms located in five Moroccan regions (Casablanca-Settat, Rabat-Salé-Kenitra, Souss-Massa, Fes-Meknes, and Beni Mellal-Khenifra) were included in this cross-sectional observational study. Among them, 130 rectal swabs were collected from diarrheic calves between November 2022 and March 2023 and analyzed using reverse transcription quantitative PCR (RT-qPCR). The results indicated that 34% of diarrheic calves tested positive for RVA and 62% for BCoV, with a co-infection rate of 24%. Infection rates were influenced by several factors, including calf age, geographic region, dam vaccination status, calving rank, production system, and farm size. RVA infection peaked in calves aged 8–14 days, whereas BCoV was most prevalent in calves aged 21–29 days. Notably, RVA positivity was higher in calves born to vaccinated dams (40%) compared to those from unvaccinated dams (20%), while BCoV infection was more frequently detected in calves from heifers than from multiparous cows. Higher infection rates in calves were also observed in intensive farming systems. Overall, these findings confirmed the major role of rotavirus and bovine coronavirus in neonatal calf diarrhea in Morocco and suggest that the limited effectiveness of vaccination may be influenced by herd management, colostrum transfer, and biosecurity practices. The potential mismatch between vaccine and circulating strains highlights the need for continuous molecular surveillance.
- 30 June 2026
- Published by Scienceline Publication in World's Veterinary Journal
- Vol. 16 (2) , 436
Open AccessMolecular Investigation and Risk Assessment of Neonatal Calf Diarrhea in Morocco: Emphasis on Rotavirus and Coronavirus Infections
Neonatal calf diarrhea represents a major health and economic burden in Moroccan cattle farming and remains a leading cause of calf mortality. It is commonly associated with infectious agents such as rotavirus, bovine coronavirus, Escherichia coli, and Cryptosporidium parvum, and is often aggravated by dehydration and electrolyte imbalances. The present study aimed to update the epidemiological profile of viral pathogens involved in neonatal calf diarrhea in Morocco, with particular emphasis on rotavirus group A (RVA) and bovine coronavirus (BCoV). A total of 889 newborn calves from 20 farms located in five Moroccan regions (Casablanca-Settat, Rabat-Salé-Kenitra, Souss-Massa, Fes-Meknes, and Beni Mellal-Khenifra) were included in this cross-sectional observational study. Among them, 130 rectal swabs were collected from diarrheic calves between November 2022 and March 2023 and analyzed using reverse transcription quantitative PCR (RT-qPCR). The results indicated that 34% of diarrheic calves tested positive for RVA and 62% for BCoV, with a co-infection rate of 24%. Infection rates were influenced by several factors, including calf age, geographic region, dam vaccination status, calving rank, production system, and farm size. RVA infection peaked in calves aged 8–14 days, whereas BCoV was most prevalent in calves aged 21–29 days. Notably, RVA positivity was higher in calves born to vaccinated dams (40%) compared to those from unvaccinated dams (20%), while BCoV infection was more frequently detected in calves from heifers than from multiparous cows. Higher infection rates in calves were also observed in intensive farming systems. Overall, these findings confirmed the major role of rotavirus and bovine coronavirus in neonatal calf diarrhea in Morocco and suggest that the limited effectiveness of vaccination may be influenced by herd management, colostrum transfer, and biosecurity practices. The potential mismatch between vaccine and circulating strains highlights the need for continuous molecular surveillance.
- Open Access
- 31 January 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (1)
Functional characterization and safety assessment of indigenous lactic acid bacteria from Moroccan artisanal dairy products with probiotic, health‐promoting, and antimicrobial activities
- 31 January 2026
- Published by Elsevier in Applied Food Research
- Vol. 6 (1)
Open AccessFunctional characterization and safety assessment of indigenous lactic acid bacteria from Moroccan artisanal dairy products with probiotic, health‐promoting, and antimicrobial activities
- 2 July 2024
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 71 (2) , 134-139
Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates
The rate of pandrug-resistant Acinetobacter baumannii strains is on the rise in all continents. This bacterium can acquire resistance to all antibiotics, even to colistin. Alterations in the lipid A or/and the two-component pmrAB were earlier detected in colistin resistance. We investigated and analyzed two strains of A. baumannii (ABRC1 and ABRC2) isolated from two patients admitted to intensive care unit with a septic shock. Both strains were resistant to all tested antibiotics including colistin with a MIC >256 mg L−1. Colistin resistance genes (pmrA, pmrB, lpxA, lpxC, lpxD, and lpsB) of two strains (ABRC1 and ABRC2) were investigated by PCR and sequencing. Obtained nucleic acid sequences were aligned with reference sequences of ATCC 19606 and 17987. In this study two amino acid mutations, N287D in the lpxC gene and E117K in the lpxD gene, were detected in both ABRC1 and ABRC2 strains. ABRC1 had an additional H200L mutation in the pmrA gene. Both colistin resistant strains harbored the same A138T mutation in the pmrB gene. The ABRC2 strain also had an alteration in the kinase domain, specifically an R263S substitution of the histidine kinase domain. Three identical mutations were found in the lpsB gene of both A. baumannii strains: Q216K + H218G + S219E. As a result, a newly deduced protein sequence in both ABRC1 and ABRC2 strains differed from those described in ATCC 17978 and 19606 strains was determined. Colistin resistance is multifactorial in A. baumannii. In our study we detected novel mutations in colistin resistant A. baumannii clinical isolates.
- 2 July 2024
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 71 (2) , 134-139
Genetic alterations in the pmrAB two-component system and lipid A biosynthesis genes of polymyxin-resistant Acinetobacter baumannii isolates
The rate of pandrug-resistant Acinetobacter baumannii strains is on the rise in all continents. This bacterium can acquire resistance to all antibiotics, even to colistin. Alterations in the lipid A or/and the two-component pmrAB were earlier detected in colistin resistance. We investigated and analyzed two strains of A. baumannii (ABRC1 and ABRC2) isolated from two patients admitted to intensive care unit with a septic shock. Both strains were resistant to all tested antibiotics including colistin with a MIC >256 mg L−1. Colistin resistance genes (pmrA, pmrB, lpxA, lpxC, lpxD, and lpsB) of two strains (ABRC1 and ABRC2) were investigated by PCR and sequencing. Obtained nucleic acid sequences were aligned with reference sequences of ATCC 19606 and 17987. In this study two amino acid mutations, N287D in the lpxC gene and E117K in the lpxD gene, were detected in both ABRC1 and ABRC2 strains. ABRC1 had an additional H200L mutation in the pmrA gene. Both colistin resistant strains harbored the same A138T mutation in the pmrB gene. The ABRC2 strain also had an alteration in the kinase domain, specifically an R263S substitution of the histidine kinase domain. Three identical mutations were found in the lpsB gene of both A. baumannii strains: Q216K + H218G + S219E. As a result, a newly deduced protein sequence in both ABRC1 and ABRC2 strains differed from those described in ATCC 17978 and 19606 strains was determined. Colistin resistance is multifactorial in A. baumannii. In our study we detected novel mutations in colistin resistant A. baumannii clinical isolates.
- Open Access
- 1 July 2024
- Published by Microbiology Society in Access Microbiology
- Vol. 6 (7) , 000822.v3
Phenotypic and genotypic characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Moroccan hospital
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) is a major public health problem in hospitals and in the community. The objective of this work was to describe the epidemiology of ESBL-E, to study their resistance profile and to determine the genes encoding the ESBL phenotype. This is a retrospective study conducted in the bacteriology laboratory of the Mohamed V Military Training Hospital in Rabat, and covering all isolates of Enterobacteriaceae from 1 January 2018 to 31 December 2020. The molecular study of ESBL genes involved a representative sample of all ESBL isolates. The overall prevalence of ESBLs in isolated Enterobacteriaceae (1402/10268) is 13.65 %. The urinary tract was the main site of isolation of ESBL (61 %). The bacterial species most concerned are Escherichia coli (41.9 %), Klebsiella pneumoniae (42.2 %) and Enterobacter cloacae (11.9 %). The study of antibiotic susceptibility showed a resistant profile marked mainly by 100 % resistance to first generation cephalosporins (1GC) and third generation cephalosporins (3GC), 55 % to piperacillin-tazobactam, 16 % to imipenem, and 87 % to fluoroquinolones. Molecular typing of ESBL strains showed a prevalence of CTX-M (95 %), SHV (50 %) and TEM (56 %). The CTX-M-1 and the CTX-M-9 groups were the most common (96.19 % and 7.62 % respectively), and CTX-M15 was found in 78.10 % of CTX-M-1 ESBL positive isolates. Most strains had more than two coexisting resistance genes. The prevalence rate of ESBL-E is critical, and preventive action at different levels (prescriber, biologist, hospital, patient, etc.) are necessary in order to limit their spread and to manage a better therapeutic strategy.
- 1 July 2024
- Published by Microbiology Society in Access Microbiology
- Vol. 6 (7) , 000822.v3
Open AccessPhenotypic and genotypic characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a Moroccan hospital
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) is a major public health problem in hospitals and in the community. The objective of this work was to describe the epidemiology of ESBL-E, to study their resistance profile and to determine the genes encoding the ESBL phenotype. This is a retrospective study conducted in the bacteriology laboratory of the Mohamed V Military Training Hospital in Rabat, and covering all isolates of Enterobacteriaceae from 1 January 2018 to 31 December 2020. The molecular study of ESBL genes involved a representative sample of all ESBL isolates. The overall prevalence of ESBLs in isolated Enterobacteriaceae (1402/10268) is 13.65 %. The urinary tract was the main site of isolation of ESBL (61 %). The bacterial species most concerned are Escherichia coli (41.9 %), Klebsiella pneumoniae (42.2 %) and Enterobacter cloacae (11.9 %). The study of antibiotic susceptibility showed a resistant profile marked mainly by 100 % resistance to first generation cephalosporins (1GC) and third generation cephalosporins (3GC), 55 % to piperacillin-tazobactam, 16 % to imipenem, and 87 % to fluoroquinolones. Molecular typing of ESBL strains showed a prevalence of CTX-M (95 %), SHV (50 %) and TEM (56 %). The CTX-M-1 and the CTX-M-9 groups were the most common (96.19 % and 7.62 % respectively), and CTX-M15 was found in 78.10 % of CTX-M-1 ESBL positive isolates. Most strains had more than two coexisting resistance genes. The prevalence rate of ESBL-E is critical, and preventive action at different levels (prescriber, biologist, hospital, patient, etc.) are necessary in order to limit their spread and to manage a better therapeutic strategy.
- Open Access
- 19 May 2023
- Published by Wiley in International Journal of Microbiology
- Vol. 2023, 1-10
Predominance of OXA-48 Carbapenemase-Producing Enterobacterales in a Moroccan Hospital
Objective. The emergence of carbapenemase-producing Enterobacterales (CPE) is a major concern that is increasingly reported worldwide. Our study aimed at investigating the resistance of CPE isolates in a Moroccan teaching hospital using phenotypic and genotypic methods. Methods. Enterobacterales strains from March to June 2018 were collected from different clinical samples. The Enterobacterales isolates resistant to third-generation cephalosporins (3GC) and/or carbapenems were subjected to the Carba NP test and an immunochromatographic test for phenotypic detection. Detection of extended-spectrum β-lactamases (ESBL) was also performed following standards. Molecular screening of carbapenemases genes (OXA-48, NDM, blaKPC, blaIMP, blaVIM, and blaOXA-24, blaOXA-23, OXA-51, OXA-58) using conventional multiplex PCR assays was also performed on 143 isolates. Results. Enterobacterales represented 52.7 with a proportion of 21.8 of bacteria resistant to 3GC and/or carbapenems. Within 143 isolates MDR to 3GC, K. pneumoniae, E. coli, and E. cloacae represent 53.1, 40.6, and 6.3, respectively. These strains were isolated mainly from urinary samples (74.8) in patients admitted to emergency and surgical units. 81.1 of strains are producing ESBL and 29 are carbapenemase producers as confirmed by the Carba NP test, immunochromatographic test, and molecular testing. OXA-48 carriers represent 83.3 of these strains, followed by NDM with 16.7. blaKPC, blaIMP, blaVIM, and blaOXA-24, blaOXA-23, OXA-51, OXA-58 were not detected in any of these bacteria. Conclusions. A high rate of CPE carrying OXA-48 among Enterobacterales resistant to 3GC and/or carbapenems isolates was found. Strict observance of hospital hygiene measures and more rational use of antibiotics are mandatory. Implantation of carbapenemases detection should be encouraged in our hospital settings to estimate the true burden of the CPE.
- 19 May 2023
- Published by Wiley in International Journal of Microbiology
- Vol. 2023, 1-10
Open AccessPredominance of OXA-48 Carbapenemase-Producing Enterobacterales in a Moroccan Hospital
Objective. The emergence of carbapenemase-producing Enterobacterales (CPE) is a major concern that is increasingly reported worldwide. Our study aimed at investigating the resistance of CPE isolates in a Moroccan teaching hospital using phenotypic and genotypic methods. Methods. Enterobacterales strains from March to June 2018 were collected from different clinical samples. The Enterobacterales isolates resistant to third-generation cephalosporins (3GC) and/or carbapenems were subjected to the Carba NP test and an immunochromatographic test for phenotypic detection. Detection of extended-spectrum β-lactamases (ESBL) was also performed following standards. Molecular screening of carbapenemases genes (OXA-48, NDM, blaKPC, blaIMP, blaVIM, and blaOXA-24, blaOXA-23, OXA-51, OXA-58) using conventional multiplex PCR assays was also performed on 143 isolates. Results. Enterobacterales represented 52.7 with a proportion of 21.8 of bacteria resistant to 3GC and/or carbapenems. Within 143 isolates MDR to 3GC, K. pneumoniae, E. coli, and E. cloacae represent 53.1, 40.6, and 6.3, respectively. These strains were isolated mainly from urinary samples (74.8) in patients admitted to emergency and surgical units. 81.1 of strains are producing ESBL and 29 are carbapenemase producers as confirmed by the Carba NP test, immunochromatographic test, and molecular testing. OXA-48 carriers represent 83.3 of these strains, followed by NDM with 16.7. blaKPC, blaIMP, blaVIM, and blaOXA-24, blaOXA-23, OXA-51, OXA-58 were not detected in any of these bacteria. Conclusions. A high rate of CPE carrying OXA-48 among Enterobacterales resistant to 3GC and/or carbapenems isolates was found. Strict observance of hospital hygiene measures and more rational use of antibiotics are mandatory. Implantation of carbapenemases detection should be encouraged in our hospital settings to estimate the true burden of the CPE.